With a global presence in more than90 countries, Grifols had long established itself as a standard-bearer within the plasma therapies industry.
With the number of counterfeit drug investigations having grown almost tenfold in the last five years, the number of prescription drug shortages nearly tripling from 2005 to 2010, and with recent indications that this threat is increasing rather than diminishing, keeping patients safe has never been more challenging.
High school athlete Jessica Hayes was healthy, active and had no family history of blood disorders. Her sudden-onset diagnosis of acquired hemophilia demonstrates the unpredictable nature of this rare and often life-threatening disease.
Abbie Cornett, chair and president of The Alliance for Biotherapeutics, advocates for patients who lack access to lifesaving therapies, have reimbursement restrictions and/or are denied coverage.
In the world of immune globulin, the demonstrated potential of these miraculous proteins to save and sustain lives is often thwarted by the complex and intertwined encumbrances that continually create barriers to access.
After being misdiagnosed with indigestion, Carolyn Thomas lived to tell what it’s like to be a heart attack survivor. Her mission? To help other women foil this all-too-common killer.
In this issue of BioSupply Trends Quarterly, we honor the past as we look to an exciting future where once-prominent diseases will continue to be minimized or even eradicated.
A rare neuromuscular disease left once-active senior Thelma Christison too weak to get out of bed. But intravenous immune globulin has helped her to significantly recover